These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5434557)

  • 21. [Gamma globulin production in Czechoslovakia by a modified version of Cohn's fractionation method].
    FOUKAL Z; PROSEK J; VEPREKOVA A
    Experientia; 1956 Oct; 12(10):402-4. PubMed ID: 13375645
    [No Abstract]   [Full Text] [Related]  

  • 22. Depletion of preformed antibody in primates for discordant xenotransplantation by continuous donor organ plasma perfusion.
    Brewer RJ; Del Rio MJ; Roslin MS; Sadeghian M; Zisbrod Z; Burack JH; Cunningham JN; Norin AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):385-6. PubMed ID: 8438346
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbamylcholine modulation of E-rosette formation. Effect of plasmapheresis in myasthenia gravis.
    Mizuno Y; Humphrey J; Dosch HM; Gelfand EW
    Clin Exp Immunol; 1982 Jul; 49(1):209-16. PubMed ID: 6982131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation of Cohn's fraction IV which contains PTC (plasma thromboplastin component)].
    CONTE MAROTTA R; POSTIGLIONE F; ROMANO E
    Prog Med (Napoli); 1955 Apr; 11(8):243-6. PubMed ID: 14395335
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of centrifugation-related artificial gravity on the human organism. Positive and negative effects].
    Vil'-Vil'iams IF; Kotovskaia AR
    Aviakosm Ekolog Med; 2003; 37(2):11-6. PubMed ID: 12722419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The therapeutic significance of plasmapheresis in immunologic diseases].
    Wegmüller E
    Schweiz Med Wochenschr; 1981 Mar; 111(13):443-9. PubMed ID: 6112794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Technical consideration of setting up a specification for human centrifuge evaluation of anti-G equipment].
    Zhang CL; Geng XC; Zhang WX; Yan GD; Chu X
    Space Med Med Eng (Beijing); 1999 Dec; 12(6):441-5. PubMed ID: 12434812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia].
    Pérez Nellar J; Domínguez AM; Llorens-Figueroa JA; Ferrá-Betancourt A; Pardo A; Quiala M; Gali Z
    Rev Neurol; 2001 Sep 1-15; 33(5):413-6. PubMed ID: 11727205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic plasmapheresis by continuous flow cnetrifugation.
    Blacklock HA; Hill RS; Bridle M; Simpson IJ; Matthews JR; Woodfield DG
    N Z Med J; 1980 Aug; 92(666):145-8. PubMed ID: 6933347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmapheresis therapy in a patient with multiple myeloma.
    Paul M; Walker F; Bear RA
    Can Med Assoc J; 1982 Nov; 127(10):956. PubMed ID: 7139441
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
    Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
    Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high acceleration programmable centrifuge used in purification of myocardial and skeletal muscle myosins.
    Wikman-Coffelt J; Coffelt RJ
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):299-311. PubMed ID: 6452672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The production and properties of human immunoglobulin G-anti-D (Halle)].
    Tesar V
    Dtsch Gesundheitsw; 1970 Apr; 25(16):741-5. PubMed ID: 5483718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical plasmapheresis in the treatment of diabetic neuropathy].
    Gorbacheva FE; Alekseeva ME; Zinovéva OE; Parfenov VA; Koroleva TV
    Klin Med (Mosk); 1994; 72(4):34-6. PubMed ID: 7990374
    [No Abstract]   [Full Text] [Related]  

  • 38. An alternate explanation for the decrease in pemphigus antibodies with combination treatment of double-filtration plasmapheresis and IVIg.
    Habib N; Bystryn JC
    Eur J Dermatol; 2009; 19(2):190; author reply 191. PubMed ID: 19106059
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.